Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.012 | 0.7 |
mRNA | CBB-1007 | CTRPv2 | pan-cancer | AAC | 0.021 | 0.7 |
mRNA | PD-0325901 | gCSI | pan-cancer | AAC | -0.02 | 0.7 |
mRNA | Panobinostat | CTRPv2 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | BRD-K94991378 | CTRPv2 | pan-cancer | AAC | -0.015 | 0.7 |
mRNA | GW 441756 | GDSC1000 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | CH5424802 | GDSC1000 | pan-cancer | AAC | -0.012 | 0.7 |
mRNA | Tamoxifen | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | silmitasertib | CTRPv2 | pan-cancer | AAC | -0.014 | 0.7 |
mRNA | S-Trityl-L-cysteine | GDSC1000 | pan-cancer | AAC | -0.018 | 0.7 |